Autoantibodies in patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 2, 2008, Pages 156-163

  Feghali Bostwick, Carol A ^a   Gadgil, Aneal S ^a   Otterbein, Leo E ^b   Pilewski, Joseph M ^a   Stoner, Michael W ^a   Csizmadia, Eva ^b   Zhang, Yingze ^a   Sciurba, Frank C ^a   Duncan, Steven R ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; B cells; Emphysema; Humoral immunity

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; COMPLEMENT COMPONENT C3;

ADULT; ARTICLE; AUTOIMMUNITY; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LUNG ALVEOLUS EPITHELIUM; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SMOKING; SPIROMETRY; AGED; BLOOD; CASE CONTROL STUDY; EPITHELIUM; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; LUNG; MIDDLE AGED;

AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; COMPLEMENT C3; EPITHELIUM; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC TECHNIQUES; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 38349070654     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200701-014OC     Document Type: Article

References (48)

1. Centers for Disease Control and Prevention. Achievements in public health, 1900-1999: tobacco use - United States, 1900-1999. Morb Mortal Wkly Rep 1999;48:986-993.
2. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121:121S-126S.
3. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56:515-548.
4. Lange P, Parner J, Vestbo J, Schnor P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200.
5. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax 2003;58:832-834.
6. Voelkel N, Taraseviciene-Stewart L. Emphysema: an autoimmune disease? Proc Am Thorac Soc 2005;2:23-25.
7. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004;1:75-83.
8. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995;152:1666-1672.
9. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998;158:1277-1285.
10. Hogg JC, Chu F, Utokaparch S, Woods R, Elliot WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
11. Gadgil A, Zhu X, Sciurba F, Duncan S. Altered T-cell phenotypes in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:487-488.
12. Monaco C, Andreakos E, Kiriakidis S, Feldman M, Paleolog C. T-cell mediated signaling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Curr Drug Targets Inflamm Allergy 2004;3:35-42.
13. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001;7:899-905.
14. Parker DC. T-cell-dependent B-cell activation. Annu Rev Immunol 1993;11:331-340.
15. Gadgil AS, Feghali-Bostwick C, Sciurba FC, Duncan SR. Presence of circulating anti-epithelial antibodies in COPD [abstract]. Proc Am Thorac Soc 2006;3:A780.
16. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
17. Devor DD, Pilewski JM. UTP inhibits Na+ absorption in wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. Am J Physiol Cell Physiol 1999;276:C827-C837.
18. Feghali-Bostwick C, Medsger TA, Wright TM. Analysis of systemic sclerosis in twins reveals low concordances for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003;48:1956-1963.
19. 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC). In: Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. Hoboken, NJ: John Wiley and Sons; 2006. pp. 7.27.1-7.27.8.
20. Livingstone A. DNA fragmentation assay (JAM test) for measuring CTL activity. In: Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W, editors. Current Protocols in Immunology. Hoboken, NJ: John Wiley and Sons, Inc., 2006:3.11.7-3.11.1.
21. Goodwin JS, Searles RP, Tung KS. Immunologic responses of healthy elderly populations. Clin Exp Immunol 1982;48:403-441.
22. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-376.
23. Ermann J, Fathman CG. Autoimmune diseases: genes, bugs, and failed regulation. Nat Immunol 2001;2:759-761.
24. th edition, 2005, Table A-3, page 2613.
25. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, Lee A, Al-Abed Y, Vlassara H, Bucala R, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 1997;94:13915-13920.
26. Guerassimov A, Zhang Y, Banerjee S, Cartman A, Webber C, Esdaile J, Fitzcharies MA, Poole AR. Autoimmunity to cartilage link proteins in patients with rheumatoid arthritis and ankylosing spondilitis. J Rheumatol 1998;25:1480-1484.
27. Lee S-H, Goswami S, Grudo A, Song L-Z, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-569.
28. Nicoloff G, Weiss AS, Iotova V, Tzaneva V, Petrova C, Domuschieva N, Nikolov A, Tzvetanov P, Christova P. Abnormal levels of serum anti-elastin antibodies in children with diabetes mellitus type 1. J Investig Med 2006;54:461-467.
29. Konova E, Atanasova M, Stoykov S, Velkova A, Shoenfeld Y. Idiotypic and anti-idiotypic elastin autoantibodies: implications for IVIg and pregnancy loss. J Autoimmun 2007;28:46-54.
30. Daskalova M, Taskov H, Dimitrova E, Baydanoff S. Humoral and cellular immune response to elastin in patients with systemic sclerosis. Autoimmunity 1997;25:233-241.
31. Oldstone MB. Molecular mimicry, microbial infection and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol 2005;296:1-17.
32. Vanderlugt CL, Miller SD. Epitope spreading in immunemediated diseases: implications for immunotherapy. Nat Rev Immunol 2002;2:85-94.
33. Qvarfordt L, Riise GC, Andersson BA, Larsson S. Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations. Respir Med 2000;94:881-887.
34. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:991-998.
35. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999;14:1015-1022.
36. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S, Hogg JC. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001;164:469-473.
37. Adlowitz DG, Kirkham C, Sethi S, Murphy TF. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease. FEMS Immunol Med Microbiol 2006;46:139-146.
38. Croxford JL, Olson JK, Miller SD. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun Rev 2002;1:251-260.
39. Wallace WAH, Howie SM. Upregulation of tenascin and TGF-β production in a type II alveolar epithelial cell line by antibody against a pulmonary auto-antigen. J Pathol 2001;195:251-256.
40. Shifen A, Mecham RP. The stumbling block in lung repair of emphysema: elastic fiber assembly. Proc Am Thorac Soc 2006;3:428-433.
41. Silverman EK. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc 2006;3:405-408.
42. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-580.
43. Steen VD, Powell DL, Medsger TA. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
44. Reimer G, Steen VD, Penning CA, Medsger TA, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988;31:525-532.
45. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicholls MR, Fontenot AP, Tuder RM, Voelkel NF. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005;171:734-742.
46. Bosken CH, Hards J, Gatter K, Hogg JC. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis 1992;145:911-917.
47. van der Strate BWA, Postma DS, Brandsma C-A, Melgert BN, Luinge MA, Geerlings M, Hylkema MN, van den Berg A, Timens W, Kerstjens HAM. Cigarette smoke-induced emphysema: a role for the B cell? Am J Respir Crit Care Med 2006;173:751-758.
48. Colombat M, Stern M, Groussard O, Droz D, Brauner M, Valeyre D, Mal H, Taille C, Monnet I, Fournier M, et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med 2006;173:777-780.